$251 Million is the total value of Nextech Invest Ltd.'s 14 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | $99,794,581 | +20.8% | 4,189,529 | 0.0% | 39.70% | +48.8% | |
| EQRX INC | $32,236,883 | -50.3% | 13,104,424 | 0.0% | 12.82% | -38.8% | ||
| TYRA BIOSCIENCES INC | $19,141,223 | -13.5% | 2,518,582 | 0.0% | 7.62% | +6.5% | ||
| SBTX | ARS PHARMACEUTICALS INC | $16,292,547 | +61.6% | 1,910,029 | 0.0% | 6.48% | +99.0% | |
| KNTE | Sell | KINNATE BIOPHARMA INC | $14,209,828 | -55.3% | 2,329,480 | -12.5% | 5.65% | -45.0% |
| CGEM | CULLINAN ONCOLOGY INC | $12,883,080 | -17.7% | 1,221,145 | 0.0% | 5.12% | +1.4% | |
| PMVP | PMV PHARMACEUTICALS INC | $12,056,521 | -26.9% | 1,385,807 | 0.0% | 4.80% | -10.0% | |
| MRTX | MIRATI THERAPEUTICS INC | $11,957,943 | -35.1% | 263,914 | 0.0% | 4.76% | -20.1% | |
| ARVN | ARVINAS INC | $9,826,857 | -23.1% | 287,251 | 0.0% | 3.91% | -5.3% | |
| BPMC | BLUEPRINT MEDICINES CORP | $8,246,269 | -33.5% | 188,228 | 0.0% | 3.28% | -18.1% | |
| RLAY | RELAY THERAPEUTICS INC | $7,103,746 | -33.2% | 475,485 | 0.0% | 2.83% | -17.8% | |
| THESEUS PHARMACEUTICALS INC | $3,044,324 | -14.1% | 611,310 | 0.0% | 1.21% | +5.8% | ||
| KRON | KRONOS BIO INC | $2,351,490 | -51.6% | 1,451,537 | 0.0% | 0.94% | -40.5% | |
| CCCC | C4 THERAPEUTICS INC | $2,217,556 | -32.7% | 375,857 | 0.0% | 0.88% | -17.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| REVOLUTION MEDICINES INC | 8 | Q3 2023 | 44.0% |
| EQRX INC | 8 | Q3 2023 | 23.5% |
| TYRA BIOSCIENCES INC | 8 | Q3 2023 | 16.9% |
| KINNATE BIOPHARMA INC | 8 | Q3 2023 | 14.0% |
| CULLINAN ONCOLOGY INC | 8 | Q3 2023 | 5.3% |
| PMV PHARMACEUTICALS INC | 8 | Q3 2023 | 8.4% |
| ARVINAS INC | 8 | Q3 2023 | 6.2% |
| SILVERBACK THERAPEUTICS INC | 8 | Q3 2023 | 6.5% |
| KRONOS BIO INC | 8 | Q3 2023 | 5.2% |
| THESEUS PHARMACEUTICALS INC | 8 | Q3 2023 | 2.3% |
View Nextech Invest Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-01 |
| 13F-HR/A | 2022-05-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Nextech Invest Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.